2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
Insurance Revenue | -- | -- | -- | -- | -- | -- |
Interest Income | -- | -- | -- | -- | -- | -- |
Turnover | -- | -- | -- | -- | -- | -- |
Gross Premium Income | 99,755,335 | 11.802% | 89,225,048 | 162,731,563 | 161,573,844 | 144,972,748 |
Net Premium Income | 91,399,010 | 12.098% | 81,535,240 | 144,039,942 | 146,082,394 | 127,743,028 |
Investment Income/(Loss) | 7,849,335 | 56.587% | 5,012,756 | 12,149,698 | 11,403,166 | 10,175,904 |
Net Realised Gains/(Losses) on Assets | -- | -- | -- | 4,377,169 | 5,287,410 | 441,121 |
Net Fair Value Gains / (Losses) on Assets | -- | -- | -- | (1,762,817) | (1,002,043) | 699,380 |
Other Income/(Loss) | 1,790,201 | -18.141% | 2,186,930 | 5,169,625 | 6,424,188 | 3,574,758 |
Total Revenues | 101,038,546 | 13.866% | 88,734,926 | 163,973,617 | 168,195,115 | 142,634,191 |
Insurance Service Expenses | -- | -- | -- | -- | -- | -- |
Net Expenses from Reinsurance Contracts | -- | -- | -- | -- | -- | -- |
Net Finance (Expenses)/Income from Insurance Contracts | -- | -- | -- | -- | -- | -- |
Net Finance (Expenses)/Income from Reinsurance Contracts | -- | -- | -- | -- | -- | -- |
Net Impairment Loss | -- | -- | -- | -- | -- | -- |
Other Expenses | (96,673,056) | 9.060% | (88,641,723) | (158,551,804) | (162,994,427) | (136,706,635) |
Other Non-operating Items | -- | -- | (871,954) | 0 | 0 | 0 |
Share of results of Associates & JCEs | 1,959,788 | -- | (589,649) | 1,686,425 | 2,097,055 | 2,140,117 |
Profit / (Loss) before Taxation | 6,325,278 | -- | (1,368,400) | 7,108,238 | 7,297,743 | 8,067,673 |
Taxation | (534,685) | -- | 493,052 | (1,213,464) | (1,373,909) | (1,422,359) |
Profit / (Loss) for Discontinued Operations | -- | -- | -- | -- | -- | -- |
Non-controlling Interests | (138,147) | -- | 550,703 | 59,288 | (213,303) | (595,969) |
Others | -- | -- | -- | -- | -- | -- |
Profit/ (Loss) Attributable to Shareholders | 5,652,446 | -- | (324,645) | 5,954,062 | 5,710,531 | 6,049,345 |
2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
Depreciation & Amortisation | 1,305,622 | 1.695% | 1,283,855 | 1,238,046 | 1,216,516 | 1,165,054 |
Directors' Emoluments | 2,723 | -20.751% | 3,436 | 3,511 | 4,737 | 3,530 |
2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
EPS (cts) | 13.000 | -- | -1.000 | 14.000 | 13.000 | 14.000 |
DPS (cts) | 4.200 | -- | 1.400 | 4.500 | 4.100 | 4.400 |
Dividend Payout Ratio (%) | 32.308% | -- | -- | 32.143% | 31.538% | 31.429% |
Cash flow per share ($) | 0.384 | -- | 0.276 | 0.225 | 0.783 | 0.397 |
NBV per share ($) | 2.195 | -- | 2.086 | 2.182 | 2.190 | 2.051 |
Remarks: | Real time quote last updated: 23/08/2024 18:00 |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
Profit / (Loss) Attributable to Shareholders (K¥) | RMB 5,652,446 |
%Change | -- |
EPS / (LPS) | RMB 0.130 |
NBV Per Share (¥) | RMB 2.195 |